Cargando…
Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibro...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919195/ https://www.ncbi.nlm.nih.gov/pubmed/31890348 http://dx.doi.org/10.1167/tvst.8.6.36 |
_version_ | 1783480724231290880 |
---|---|
author | Valiente-Soriano, Francisco J. Ortín-Martínez, Arturo Di Pierdomenico, Johnny García-Ayuso, Diego Gallego-Ortega, Alejandro Miralles de Imperial-Ollero, Juan A. Jiménez-López, Manuel Villegas-Pérez, María Paz Wheeler, Larry A. Vidal-Sanz, Manuel |
author_facet | Valiente-Soriano, Francisco J. Ortín-Martínez, Arturo Di Pierdomenico, Johnny García-Ayuso, Diego Gallego-Ortega, Alejandro Miralles de Imperial-Ollero, Juan A. Jiménez-López, Manuel Villegas-Pérez, María Paz Wheeler, Larry A. Vidal-Sanz, Manuel |
author_sort | Valiente-Soriano, Francisco J. |
collection | PubMed |
description | PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF). METHODS: In anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1(+)monocytic cells, TUNEL(+) cells and S-opsin(+) cone outer segments were examined up to 7 days. Left eyes were treated topically with BMD (1%) or vehicle, before or right after LIP, or intravitreally with BDNF (2.5 μg), CNTF (0.2 μg), bFGF (0.5 μg), or corresponding vehicle right after LIP. At 7 days, S-opsin(+) cone outer segments were counted within predetermined fixed-size areas (PFA) centered on the lesion in both flattened retinas. RESULTS: SD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 μm to 160.7 ± 6.8 μm [7 days], n = 8), increasing TUNEL(+) cells (peak at 3 days), decreasing S-opsin(+) cone outer segments, and strong microglia activation. ERGs were normal by 3 days. Total S-opsin(+) cones in the PFA for LIP-treated and fellow-retinas were 2330 ± 262 and 5601 ± 583 (n = 8), respectively. All neuroprotectants (n = 7–11), including topical BMD pre- or post-LIP, or intravitreal BDNF, CNTF, and bFGF, showed significantly greater S-opsin(+) cone survival than their corresponding vehicle-treated groups. CONCLUSIONS: LIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity. |
format | Online Article Text |
id | pubmed-6919195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-69191952019-12-30 Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity Valiente-Soriano, Francisco J. Ortín-Martínez, Arturo Di Pierdomenico, Johnny García-Ayuso, Diego Gallego-Ortega, Alejandro Miralles de Imperial-Ollero, Juan A. Jiménez-López, Manuel Villegas-Pérez, María Paz Wheeler, Larry A. Vidal-Sanz, Manuel Transl Vis Sci Technol Articles PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF). METHODS: In anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1(+)monocytic cells, TUNEL(+) cells and S-opsin(+) cone outer segments were examined up to 7 days. Left eyes were treated topically with BMD (1%) or vehicle, before or right after LIP, or intravitreally with BDNF (2.5 μg), CNTF (0.2 μg), bFGF (0.5 μg), or corresponding vehicle right after LIP. At 7 days, S-opsin(+) cone outer segments were counted within predetermined fixed-size areas (PFA) centered on the lesion in both flattened retinas. RESULTS: SD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 μm to 160.7 ± 6.8 μm [7 days], n = 8), increasing TUNEL(+) cells (peak at 3 days), decreasing S-opsin(+) cone outer segments, and strong microglia activation. ERGs were normal by 3 days. Total S-opsin(+) cones in the PFA for LIP-treated and fellow-retinas were 2330 ± 262 and 5601 ± 583 (n = 8), respectively. All neuroprotectants (n = 7–11), including topical BMD pre- or post-LIP, or intravitreal BDNF, CNTF, and bFGF, showed significantly greater S-opsin(+) cone survival than their corresponding vehicle-treated groups. CONCLUSIONS: LIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity. The Association for Research in Vision and Ophthalmology 2019-12-16 /pmc/articles/PMC6919195/ /pubmed/31890348 http://dx.doi.org/10.1167/tvst.8.6.36 Text en Copyright 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Articles Valiente-Soriano, Francisco J. Ortín-Martínez, Arturo Di Pierdomenico, Johnny García-Ayuso, Diego Gallego-Ortega, Alejandro Miralles de Imperial-Ollero, Juan A. Jiménez-López, Manuel Villegas-Pérez, María Paz Wheeler, Larry A. Vidal-Sanz, Manuel Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title_full | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title_fullStr | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title_full_unstemmed | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title_short | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity |
title_sort | topical brimonidine or intravitreal bdnf, cntf, or bfgf protect cones against phototoxicity |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919195/ https://www.ncbi.nlm.nih.gov/pubmed/31890348 http://dx.doi.org/10.1167/tvst.8.6.36 |
work_keys_str_mv | AT valientesorianofranciscoj topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT ortinmartinezarturo topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT dipierdomenicojohnny topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT garciaayusodiego topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT gallegoortegaalejandro topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT mirallesdeimperialollerojuana topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT jimenezlopezmanuel topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT villegasperezmariapaz topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT wheelerlarrya topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity AT vidalsanzmanuel topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity |